CN101884731B - Traditional Chinese medicine for treating silicosis - Google Patents

Traditional Chinese medicine for treating silicosis Download PDF

Info

Publication number
CN101884731B
CN101884731B CN2009100842032A CN200910084203A CN101884731B CN 101884731 B CN101884731 B CN 101884731B CN 2009100842032 A CN2009100842032 A CN 2009100842032A CN 200910084203 A CN200910084203 A CN 200910084203A CN 101884731 B CN101884731 B CN 101884731B
Authority
CN
China
Prior art keywords
chinese medicine
parts
traditional chinese
fine powder
radix
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2009100842032A
Other languages
Chinese (zh)
Other versions
CN101884731A (en
Inventor
刘新壮
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Suzhou Danfang Textile Research and Development Co Ltd
Original Assignee
Lvyuan Qiuzheng Technology Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lvyuan Qiuzheng Technology Development Co Ltd filed Critical Lvyuan Qiuzheng Technology Development Co Ltd
Priority to CN2009100842032A priority Critical patent/CN101884731B/en
Publication of CN101884731A publication Critical patent/CN101884731A/en
Application granted granted Critical
Publication of CN101884731B publication Critical patent/CN101884731B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a traditional Chinese medicine for treating silicosis, and belongs to the field of traditional Chinese medicines for treating respiratory diseases. The traditional Chinese medicine aims to achieve good effect and quick response. The traditional Chinese medicine is prepared from greenish lily bulb, notoginseng root, rehmanniae praeparatum, common bletilla pseudobulb, spreading hedyotis herb, glossy ganoderma,, Indian iphigenia bulb, Chinese angelica and the like, has the effects of strengthening body resistance and archaeus, supplementing qi and nourishing blood, resolving hard lumps to dissipate stagnation, promoting blood circulation by removing blood stasis and moistening lung to relieve cough, and has the advantages of obvious effect, definite curative effect and quick response.

Description

A kind of Chinese medicine for the treatment of pneumosilicosis
Technical field
The invention belongs to the field of Chinese medicines of treatment respiratory disease.
Background technology
In the Chinese medicine of treatment pneumosilicosis, exist the problem of two aspects at present: the one, effect is obvious inadequately, and the 2nd, it is slower to take effect.Owing to lack effective medicine, so that the delay of large quantities of silicotic's state of an illness constantly increases the weight of---out of breath, uncomfortable in chest, chest pain, cough, expectoration, dyspnea obstinate, be difficult to alleviate, tormenting the patient for a long time.Patient and relatives thereof are very dissatisfied.
At problem set forth above, the invention provides a kind of Chinese medicine for the treatment of pneumosilicosis, it is obvious inadequately that it can solve in this type of treatment by Chinese herbs in the past effect, the slower problem that takes effect, effective, instant effect, it is remarkable to have effect, and drug effect is definite, the advantage of quick result.
Summary of the invention
The present invention is achieved through the following technical solutions:
1, a kind of Chinese medicine for the treatment of pneumosilicosis adopts the raw material of Chinese medicine preparation, and filling a prescription is (by weight):
Bulbus Lilii 3---25 parts of 20 portions of Radix Notoginseng 3---20 parts of Radix Rehmanniae 4---
Pseudobulbus Bletillae (Rhizoma Bletillae) 3---20 parts of 20 parts of Herba Hedyotidis Diffusaes 4---25 portions of Ganodermas 3---
25 parts of Pseudobulbus Cremastrae Seu Pleioness 4---25 parts of Radix Angelicae Sinensis 4---
The Chinese medicine of this treatment pneumosilicosis is made by following method:
(1) by above-mentioned weight ratio, Bulbus Lilii, the Radix Rehmanniae, Pseudobulbus Bletillae (Rhizoma Bletillae), Herba Hedyotidis Diffusae, Pseudobulbus Cremastrae Seu Pleiones, Radix Angelicae Sinensis are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Radix Notoginseng, Ganoderma are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; As required, can be made into Chinese medicine electuary, granule, powder, capsule, watered pill, tablets and other formulations.
The present invention is according to the folk tradition prescription, and the theory according to traditional Chinese medical science the body resistance strengthening and constitution consolidating, blood circulation promoting and blood stasis dispelling develops meticulously.The basic lesion of pneumosilicosis is nodular formation of silicon and diffusivity pulmonary fibrosis, controls when enhance immunity, blood circulation promoting and blood stasis dispelling.Ganoderma, Radix Rehmanniae the body resistance strengthening and constitution consolidating, benefiting QI and nourishing blood in the side, enhancing human body immunity power, this is the important prerequisite of treatment pneumosilicosis; Pseudobulbus Cremastrae Seu Pleiones, Herba Hedyotidis Diffusae heat clearing away dissipating blood stasis, hard masses softening and resolving, subduing swelling and detoxicating; 5 with Radix Angelicae Sinensis, pseudo-ginseng blood-circulation-invigovating blood stasis dispelling, the mediation blood vessels, and to strengthen the microcirculation of lung tissue, this is the nodular key of the silicon of dissolving lung; Be aided with Pseudobulbus Bletillae (Rhizoma Bletillae) tonifying the lung void, cough-relieving is coughed, lung heat clearing consumptive disease hemoptysis; The Bulbus Lilii nourishing the lung to arrest cough, clearing away heart-fire for tranquillization is used to control the deficient chronic cough of dryness of the lung lung-heat.All medicine compatibilities bring out the best in each other, and play the body resistance strengthening and constitution consolidating altogether, benefiting QI and nourishing blood, and hard masses softening and resolving, blood circulation promoting and blood stasis dispelling, the merit of nourishing the lung to arrest cough, effective, instant effect, it is remarkable to have effect, and drug effect is definite, the advantage of quick result.
The specific embodiment
By following embodiment the present invention is done and to specify:
1, get following prescription (weight is unit by gram):
The Bulbus Lilii 50 gram Radix Notoginseng 50 gram Radix Rehmanniae 60 grams
Pseudobulbus Bletillae (Rhizoma Bletillae) 50 gram Herba Hedyotidis Diffusaes 60 kairine sesames 40 grams
Pseudobulbus Cremastrae Seu Pleiones 60 gram Radix Angelicae Sinensis 60 grams
Weight in accordance with regulations, with conventional water extraction process Bulbus Lilii, the Radix Rehmanniae, Pseudobulbus Bletillae (Rhizoma Bletillae), Herba Hedyotidis Diffusae, Pseudobulbus Cremastrae Seu Pleiones, Radix Angelicae Sinensis are extracted, make extractum fine powder 85 grams, Radix Notoginseng, Ganoderma are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder, make fine particle, the capsule of packing into No. 0 is made 625 of Chinese medicinal capsules, and every capsules includes Chinese medicine fine powder and extract 0.28 gram.
2, get following prescription (weight is unit by gram):
The Bulbus Lilii 120 gram Radix Notoginseng 100 gram Radix Rehmanniae 120 grams
Pseudobulbus Bletillae (Rhizoma Bletillae) 120 gram Herba Hedyotidis Diffusaes 120 kairine sesames 100 grams
Pseudobulbus Cremastrae Seu Pleiones 160 gram Radix Angelicae Sinensis 160 grams
By above-mentioned same method, make 1428 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
3, get following prescription (weight is unit by gram):
The Bulbus Lilii 200 gram Radix Notoginseng 200 gram Radix Rehmanniae 250 grams
Pseudobulbus Bletillae (Rhizoma Bletillae) 200 gram Herba Hedyotidis Diffusaes 250 kairine sesames 200 grams
Pseudobulbus Cremastrae Seu Pleiones 250 gram Radix Angelicae Sinensis 250 grams
By above-mentioned same method, make 2678 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
4, get following prescription (by weight):
10 parts in 7 parts of Radix Rehmanniae of 7 portions of Radix Notoginseng of Bulbus Lilii
7 parts of 10 portions of Ganodermas of 7 parts of Herba Hedyotidis Diffusaes of Pseudobulbus Bletillae (Rhizoma Bletillae)
10 parts of 10 parts of Radix Angelicae Sinensis of Pseudobulbus Cremastrae Seu Pleiones
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
5, get following prescription (by weight):
22 parts in 18 parts of Radix Rehmanniae of 18 portions of Radix Notoginseng of Bulbus Lilii
18 parts of 22 portions of Ganodermas of 18 parts of Herba Hedyotidis Diffusaes of Pseudobulbus Bletillae (Rhizoma Bletillae)
22 parts of 22 parts of Radix Angelicae Sinensis of Pseudobulbus Cremastrae Seu Pleiones
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
Clinical data:
The present invention is an example with traditional Chinese medical science pneumosilicosis, through 21 routine clinical observations.Selecting the tcm diagnosis pneumosilicosis is standard: Mental fatigue is breathed hard, and limb is soft weak, and long dust atmosphere history is arranged; Uncomfortable in chest for a long time, chest pain, cough, breathe hard, dyspnea; X-ray examination sees that pulmonary shadow, silicon tuberosity form and the diffusivity pulmonary fibrosis.As above symptom can be made a definite diagnosis.In making a definite diagnosis the object of observation, male's 19 examples, women's 2 examples do not have other serious disease, and the age is 41 years old-66 years old, 55.7 years old mean age.
Efficacy determination:
1, produce effects: body constitution strengthens, and limbs are strong; Uncomfortable in chest, chest pain, cough, breathe hard, dyspnea obviously alleviates; X-ray examination sees that lung tuberosity and netted shade have the improvement of absorption phenomenon.
2, effective: body constitution strengthens, on one's body energetically; Out of breath, cough, uncomfortable in chest, chest pain etc. are alleviated to some extent.
3, invalid: the disease no change.
During clinical experiment, withdraw other medicines and health nutrient.Taking Chinese medicinal capsule of the present invention, observed 3 months, is a course of treatment.Instructions of taking: every day 3 times, each 5 capsules, every capsules include Chinese medicine fine powder and extract 0.28 gram, warm water delivery service after meal, symptom promptly has alleviation after 1 month, take 3 months after, symptom is obviously improved.21 philtrums of clinical experiment, produce effects 10 people, effective 9 people, invalid 2 people, total effective rate 90.4%.

Claims (1)

1. a Chinese medicine for the treatment of pneumosilicosis is characterized in that, described Chinese medicine is to adopt the raw material of Chinese medicine preparation, and the weight proportion of raw material of Chinese medicine is:
Bulbus Lilii 3---25 parts of 20 portions of Radix Notoginseng 3---20 parts of Radix Rehmanniae 4---
Pseudobulbus Bletillae (Rhizoma Bletillae) 3---20 parts of 20 parts of Herba Hedyotidis Diffusaes 4---25 portions of Ganodermas 3---
25 parts of Pseudobulbus Cremastrae Seu Pleioness 4---25 parts of Radix Angelicae Sinensis 4---
The Chinese medicine of this treatment pneumosilicosis is made by following method:
(1) by above-mentioned weight ratio, Bulbus Lilii, the Radix Rehmanniae, Pseudobulbus Bletillae (Rhizoma Bletillae), Herba Hedyotidis Diffusae, Pseudobulbus Cremastrae Seu Pleiones, Radix Angelicae Sinensis are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Radix Notoginseng, Ganoderma are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; As required, make Chinese medicine granules, powder, capsule, watered pill, Tabules.
CN2009100842032A 2009-05-14 2009-05-14 Traditional Chinese medicine for treating silicosis Expired - Fee Related CN101884731B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2009100842032A CN101884731B (en) 2009-05-14 2009-05-14 Traditional Chinese medicine for treating silicosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2009100842032A CN101884731B (en) 2009-05-14 2009-05-14 Traditional Chinese medicine for treating silicosis

Publications (2)

Publication Number Publication Date
CN101884731A CN101884731A (en) 2010-11-17
CN101884731B true CN101884731B (en) 2011-09-28

Family

ID=43070931

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2009100842032A Expired - Fee Related CN101884731B (en) 2009-05-14 2009-05-14 Traditional Chinese medicine for treating silicosis

Country Status (1)

Country Link
CN (1) CN101884731B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103599375B (en) * 2013-11-26 2015-09-23 张永平 One treats tuberculosis
CN105079479A (en) * 2015-09-01 2015-11-25 高丙军 Method for preventing silicosis
CN105396004A (en) * 2015-11-26 2016-03-16 重庆壹心堂贸易有限公司 Preparing method for traditional Chinese medicine used for treating pneumoconiosis

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1686529A (en) * 2005-05-20 2005-10-26 李素梅 Ready prepared Chinese medicine for treating diabetes
CN1947777A (en) * 2006-06-18 2007-04-18 芮育健 Method for treating diabets by Fuling, wolfberry fruit and radix scrophulariae with producing saliva and slaking thirst function

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1686529A (en) * 2005-05-20 2005-10-26 李素梅 Ready prepared Chinese medicine for treating diabetes
CN1947777A (en) * 2006-06-18 2007-04-18 芮育健 Method for treating diabets by Fuling, wolfberry fruit and radix scrophulariae with producing saliva and slaking thirst function

Also Published As

Publication number Publication date
CN101884731A (en) 2010-11-17

Similar Documents

Publication Publication Date Title
CN101884731B (en) Traditional Chinese medicine for treating silicosis
CN101564505B (en) Chinese medicament for treating pulmonary heart disease
CN101843829B (en) Chinese medicament for treating pulmonary heart diseases
CN101884762B (en) Traditional Chinese medicine for treating emphysema
CN101897847B (en) Traditional Chinese medicine for curing asthma
CN101850017B (en) Chinese medicament for treating asthma
CN101884704B (en) Traditional Chinese medicine for treating asthma
CN101874851B (en) Traditional Chinese medicine for treating chronic infectious arthritis
CN101843679B (en) Chinese medicament for treating cervical spondylosis
CN101843698B (en) Chinese medicament for treating cervical spondylosis
CN102018765A (en) Traditional Chinese medicine for treating diabetic acromelic gangrene
CN101850079B (en) Chinese medicament for treating asthma
CN101879259B (en) Traditional Chinese medicine for treating pulmonary heart diseases
CN101843844B (en) Chinese medicament for treating pulmonary heart diseases
CN101850083B (en) Chinese medicament for treating asthma
CN101843830B (en) Chinese medicament for treating pulmonary heart diseases
CN101843797A (en) Chinese medicament for treating pulmonary heart diseases
CN101564476B (en) Chinese medicament for treating coronary heart disease
CN101879246A (en) Traditional Chinese medicine for treating lupus erythematosus
CN101843745B (en) Chinese medicament for treating chronic hepatitis
CN101843768B (en) Chinese medicament for treating climacteric syndromes
CN101843796A (en) Chinese medicament for treating pulmonary heart diseases
CN101843732A (en) Chinese medicament for treating pulmonary heart diseases
CN101843719A (en) Chinese medicament for treating pulmonary heart diseases
CN101843868A (en) Chinese medicament for treating diabetic acro-necrosis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: SUZHOU DANFANG TEXTILE RESEARCH + DEVELOPMENT CO.,

Free format text: FORMER OWNER: BEIJING LVYUANQIUZHENG TECHNOLOGY DEVELOPMENT CO., LTD.

Effective date: 20150104

C41 Transfer of patent application or patent right or utility model
COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: 100040 SHIJINGSHAN, BEIJING TO: 215228 SUZHOU, JIANGSU PROVINCE

TR01 Transfer of patent right

Effective date of registration: 20150104

Address after: 215228 Jiangsu City, Wujiang Province, Shengze Town, No. two West Ring Road, No. Shengze Textile Science and Technology Park, building 10, 1188

Patentee after: Suzhou Danfang Textile Research & Development Co., Ltd.

Address before: 100040 Beijing city Shijingshan District street Babaoshan Lugu Village District No. 7 building 10-602 room

Patentee before: Beijing Lvyuanqiuzheng Technology Development Co., Ltd.

CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20110928

Termination date: 20190514

CF01 Termination of patent right due to non-payment of annual fee